Echo IQ is trading 10% up now at A$1.62 after an unexplained rebound from the August 7 close, with the catalyst unclear.
- The latest notable development was the August 5 formal FDA 510(k) submission for EchoSolv HF, incorporating clinical-validation results.
- No August 10 announcement directly links the submission to the move.
- Broader markets were essentially flat; interest may be continuing after recent regulatory milestones.